Hughes, D
Results showed that BPC-157 apparently reduced the cell number in the G0/G1 phase in a dose-dependent manner compared with the number in the control group (Figure 4B)
Common side effects of BPC-157 arent usually serious and may include: Mild injection site reactions (itching, redness, swelling, pain, etc.) Headaches Dizziness Nausea In rare cases, patients may experience fevers, blistering at the injection site, muscle aches, rashes, vomiting, hives, or other signs of an allergic reaction
Explore Cenexas full line of USA-made topical peptide powders below cosmetic-grade, research-pure, and formulated for consistent, verifiable results in topical and surface-level studies.